Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06283394 · ClinicalTrials.gov registry record · NA

Penn Medicine Food Market Study

A NA study of Obesity and Diabetes, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
214
Enrollment target
1
Study location

NCT06283394: Active NA study of Obesity and Diabetes, sponsored by University of Pennsylvania.

NCT06283394 is a NA study of Obesity and Diabetes that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 214 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06283394, a NA study of Obesity and Diabetes, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
214 participants
Enrollment target
1
Study location

Study Summary

The goal of this interventional study is to test ways to improve the effectiveness of a healthy foods prescription program in increasing the purchase of healthy foods for patients who have both obesity (BMI \>or= 30) and diabetes (last A1C\>8 in the 90 days from data pull). The main questions it aims to answer are: Aim 1: Examine feasibility and engagement among participants by assessing percent enrollment among those identified as eligible, rates of Instacart platform use, amount of the subsidy used each week, and amounts of healthy foods ordered. Aim 2: Examine strategies to optimize the user experience of trial participation, including communication strategies and on-boarding, to increase uptake and engagement in this and subsequent studies. Usual Care (Control): Participants in the usual care arm will not receive weekly subsidies on Instacart, and they will not receive any modifications to the virtual storefront on Instacart. They will have access to the standard Instacart platform and Instacart + memberships with $5 per week to cover service and delivery fees and delivery tips for 3 months. Intervention Arms: The four treatment groups will also each receive a $160 subsidy per month for 3 months to be used on produce (fruits and vegetables).

Primary Outcome

The primary outcome will be the total expenditures spent on fruits and vegetables (dollars spent inclusive of application of subsidies)

Conditions Studied

Interventions

  • BEHAVIORAL Storefront Choice Architecture
  • BEHAVIORAL Fresh Funds
  • BEHAVIORAL Loss Framing

Study Locations (1)

Pennsylvania

  • The University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2024-08-01
Est. Completion 2026-03-21
Phase NA
University of Pennsylvania

1,423 total trials

What the registry record for NCT06283394 still lists

NCT06283394 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Storefront Choice Architecture is the first listed.

NCT06283394 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06283394 about?

NCT06283394 is a clinical study titled "Penn Medicine Food Market Study". The goal of this interventional study is to test ways to improve the effectiveness of a healthy foods prescription program in increasing the purchase of healthy foods for patients who have both obesity (BMI \>or= 30) and diabetes (last A1C\>8 in the 90 days from data pull). The main questions it aim...

What is the current status of trial NCT06283394?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2024-08-01. Estimated completion is 2026-03-21.

What conditions does trial NCT06283394 study?

This clinical trial studies the following conditions: Obesity, Diabetes.

What interventions are being tested in trial NCT06283394?

The interventions under investigation include: Storefront Choice Architecture (BEHAVIORAL), Fresh Funds (BEHAVIORAL), Loss Framing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06283394?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06283394 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06283394's enrollment target sits among peer trials

214 299th of 1053 higher than 755 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04030507 · 214 participants · NA

    Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

  • NCT04421248 · 214 participants · Phase 4

    Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

  • NCT04667520 · 214 participants · NA

    Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment

  • NCT05418868 · 214 participants · Phase 1

    A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06283394, the US trial registry maintained by the National Library of Medicine. NCT06283394 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.